Statistics for Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
Total visits
| views | |
|---|---|
| Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis | 120 |
Total visits per month
| views | |
|---|---|
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
File Visits
| views | |
|---|---|
| Obici-2020-Quality-of-life-outcomes-in-apollo-.pdf | 132 |
| 10.14740_jmc3635.pdf | 1 |
Top country views
| views | |
|---|---|
| Germany | 49 |
| United States | 23 |
| United Kingdom | 15 |
| China | 8 |
| Ukraine | 8 |
| Israel | 3 |
| France | 2 |
| Italy | 2 |
| Japan | 2 |
| Russia | 2 |
| Singapore | 2 |
| Albania | 1 |
| Australia | 1 |
| Belgium | 1 |
| Canada | 1 |